Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Bruker Corporation

Bruker Corporation (BRKR) Stock Overview

Explore Bruker Corporation’s financial performance, market position, analyst ratings, and future outlook.

BRKR●NASDAQ
HealthcareMedical - Devices
$57.93
$1.34(2.26%)
U.S. Market opens in 2h 53m

Bruker Corporation (BRKR)

Meyka AI Score

Z

Key Financials

Market Cap8.8B
P/E Ratio-83.32
EPS (TTM)$1.99
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$66.00
3 Months$61.27
1 Year Target$39.96

BRKR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Bruker Corporation (NASDAQ: BRKR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bruker Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BRKR on the NASDAQ shows an RSI of 50.11, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $39.96 for the NASDAQ listing.

Key metrics behind Bruker Corporation's NASDAQ-traded stock include a P/E ratio of -83.32 and a market capitalization of 8.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BRKR on the NASDAQ.

Price Performance (NASDAQ: BRKR)

1-Day Change
-2.26%
5-Day Change
11.36%
1-Month Change
-1.76%
3-Month Change
32.11%
6-Month Change
58.67%
Year-to-Date (YTD) Change
22.97%
1-Year Change
67.72%
3-Year Change
-15.57%
5-Year Change
-30.14%
All-Time (Max) Change
151.21%

Contact Information

https://www.bruker.com
978 663 3660
40 Manning Road, Billerica, MA, 01821

Company Facts

110,850 Employees
IPO DateAug 4, 2000
CountryUS
Actively Trading

Frequently Asked Questions